Cleavage‐Responsive Biofactory T Cells Suppress Infectious Diseases‐Associated Hypercytokinemia (Adv. Sci. 26/2022)

Engineered T Cells In article number 2201883, Hong Nam Kim, Hee Ho Park, Wonhwa Lee, and co‐workers present chimeric T cells stably expressing therapeutic peptides for treatment of severe infectious diseases. Using lentiviral system, T cells are engineered to express multi‐level therapeutic peptides...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyelim, Son, Boram, Seo, Eun U, Kwon, Miji, Ahn, June Hong, Shin, Heungsoo, Song, Gyu Yong, Park, Eun Ji, Na, Dong Hee, Cho, Seung‐Woo, Kim, Hong Nam, Park, Hee Ho, Lee, Wonhwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Inside Back Cover
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475514/
http://dx.doi.org/10.1002/advs.202270168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475514/
http://dx.doi.org/10.1002/advs.202270168

Ejemplares similares